A benzoic-acid modified purine
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

1V209

Item No. 38318

Technical Information
Formal Name
4-[[6-amino-7,8-dihydro-2-(2-methoxyethoxy)-8-oxo-9H-purin-9-yl]methyl]-benzoic acid
CAS Number
1062444-54-5
Synonyms
  • TLR7 Agonist T7
  • Toll-Like Receptor 7 Agonist T7
Molecular Formula
C16H17N5O5
Formula Weight
Purity
≥98%
A solid
DMF: 0.1 mg/mlDMSO: 10 mg/mlPBS (pH 7.2): 0.1 mg/ml
λmax
285 nm
SMILES
OC(C1=CC=C(CN2C(NC3=C2N=C(OCCOC)N=C3N)=O)C=C1)=O
InChi Code
InChI=1S/C16H17N5O5/c1-25-6-7-26-15-19-12(17)11-13(20-15)21(16(24)18-11)8-9-2-4-10(5-3-9)14(22)23/h2-5H,6-8H2,1H3,(H,18,24)(H,22,23)(H2,17,19,20)
InChi Key
ATISKRYGYNSRNP-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    1V209 is a benzoic acid-modified purine that, when conjugated to polysaccharides or sterols, acts as a toll-like receptor 7 (TLR7) agonist.1,2 A variety of 1V209-polysaccharide conjugates, but not 1V209 alone, increase TNF-α secretion from RAW 264.7 macrophages and IL-6 secretion from bone marrow-derived dendritic cells (BMDCs; EC50s = 4.62-61.7 and 3.2-188 nM, respectively). Liposomes encapsulating 1V209-cholesterol conjugates decrease primary tumor weight, secondary tumor volume, and the number of secondary lung metastases, as well as increase tumor-associated CD8+ IFN-γ+ T cells and survival, in a CT26 colorectal cancer mouse model of tumor rechallenge and lung metastasis.2

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Shinchi, H., Crain, B., Yao, S., et alEnhancement of the immunostimulatory activity of a TLR7 ligand by conjugation to polysaccharides. Bioconjug. Chem. 26(8), 1713-1723 (2015).

    2. Wan, D., Que, H., Chen, L., et alLymph-node-targeted cholesterolized TLR7 agonist liposomes provoke a safe and durable antitumor response. Nano Lett. 21(19), 7960-7969 (2021).